UBS Group
CLX icon

UBS Group’s Clorox CLX Stock Holding History

UBS Group’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$141K – 10398
2022
Q2 		$141K Buy
1,000
+500
+100% +$71.4K ﹤0.01% 5171
2022
Q1 		$70K Sell
500
-200
-29% -$30.6K ﹤0.01% 6169
2021
Q4 		$122K Hold
700
– – ﹤0.01% 6117
2021
Q3 		$116K Buy
700
+200
+40% +$34.4K ﹤0.01% 5727
2021
Q2 		$90K Hold
500
– – ﹤0.01% 5960
2021
Q1 		$96K Sell
500
-24,600
-98% -$4.74M ﹤0.01% 5995
2020
Q4 		$5.07M Buy
25,100
+15,500
+161% +$3.21M ﹤0.01% 2438
2020
Q3 		$2.02M Buy
+9,600
New +$2.14M ﹤0.01% 3028
2018
Q2 		– Sell
-2,000
Closed -$266K – 8004
2018
Q1 		$266K Hold
2,000
– – ﹤0.01% 4591
2017
Q4 		$297K Buy
+2,000
New +$272K ﹤0.01% 4647
2017
Q3 		– Sell
-2,600
Closed -$346K – 7741
2017
Q2 		$346K Buy
2,600
+200
+8% +$27K ﹤0.01% 4385
2017
Q1 		$323K Buy
2,400
+600
+33% +$77.7K ﹤0.01% 4333
2016
Q4 		$216K Buy
1,800
+1,600
+800% +$189K ﹤0.01% 4737
2016
Q3 		$25K Buy
+200
New +$26.2K ﹤0.01% 6090
2016
Q2 		– Sell
-500
Closed -$63K – 7745
2016
Q1 		$63K Sell
500
-100
-17% -$12.7K ﹤0.01% 5313
2015
Q4 		$76K Buy
600
+500
+500% +$62.1K ﹤0.01% 5434
2015
Q3 		$12K Sell
100
-600
-86% -$67.4K ﹤0.01% 7139
2015
Q2 		$72K Hold
700
– – ﹤0.01% 5669
2015
Q1 		$77K Sell
700
-900
-56% -$97.7K ﹤0.01% 5637
2014
Q4 		$167K Buy
+1,600
New +$160K ﹤0.01% 5212

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group's CLX Position: Q2 2026 in Review

UBS Group increased its Clorox (CLX) stake by 117% in Q2 2026, buying an estimated $102M and bringing the position to 1,980,435 shares worth $189M. The position accounts for 0.02% of the portfolio, ranked #698.

UBS Group first reported a position in CLX in Q4 2014 and has held it in 47 quarters since. The position peaked at $216M in Q2 2025. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • UBS Group held 1,980,435 shares of Clorox worth $189M as of Q2 2026.
  • UBS Group bought 1,066,071 Clorox shares in Q2 2026, an estimated $102M.
  • Clorox made up 0.02% of UBS Group's portfolio in Q2 2026, its #698 holding.
  • UBS Group first reported a position in Clorox in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Clorox position peaked at $216M in Q2 2025.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.